Technology

Silicon Valley used to take a backseat to Washington, D.C. But now, the people disrupting technology have taken the wheel at the highest echelons of government. And that’s thanks, in large part, to the Department of Government Efficiency, better known as DOGE. Much reporting on DOGE has focused on its staffers’ ties to Musk, the billionaire bestie of […]

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. China built hundreds of AI data centers to catch the AI boom. Now many stand unused. Just months ago, China’s boom in data center construction was at its height, fueled by both government…

Before RJ Scaringe founded Rivian in 2009, he had micromobility on his mind. More than a decade later, his musings took root in a small skunkworks program inside Rivian that set out to answer one question: Could the company’s technology be condensed down into something smaller and more affordable than its electric vans, trucks, and SUVs? […]

A year or so ago, Xiao Li was seeing floods of Nvidia chip deals on WeChat. A real estate contractor turned data center project manager, he had pivoted to AI infrastructure in 2023, drawn by the promise of China’s AI craze.  At that time, traders in his circle bragged about securing shipments of high-performing Nvidia…

OpenAI has released a new image generator that’s designed less for typical surrealist AI art and more for highly controllable and practical creation of visuals—a sign that OpenAI thinks its tools are ready for use in fields like advertising and graphic design.  The image generator, which is now part of the company’s GPT-4o model, was…

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Ethically sourced “spare” human bodies could revolutionize medicine Many challenges in medicine stem, in large part, from a common root cause: a severe shortage of ethically-sourced human bodies. There might be a way…

Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation so long? These challenges stem in large part from a common root cause: a severe…

This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. This week’s edition of The Algorithm is brought to you not by your usual host, James O’Donnell, but Eileen Guo, an investigative reporter at MIT Technology Review.  A few weeks ago, when…

The only technology with an on-ramp to AGI.